The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 79-91

  Van Gool, W A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; BRAIN DEGENERATION; BRAIN DISEASE; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC TEST; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; LEWY BODY; MAJOR CLINICAL STUDY;

EID: 0030476824     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32601.x     Document Type: Conference Paper

References (73)

1. SCOTT, J. 1993. Apolipoprotein E and Alzheimer's disease. Lancet 342: 696.
2. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C, GASKELL, A. D. ROSES, J. L. HAINE & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families [see comments]. Science 261: 921-923.
3. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. GEORGE-HYSLOP, S. H. JOO, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MACLACHLAN, et al. 1993. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
4. SAUNDERS, A. M., K. SCHMADER, J. C. S. BREITNER, M. D. BENSON, W. T. BROWN, L. GOLDFARB, D. GOLDGABER, M. G. MANWARING, M. H. SZYMANSKI, N. MCCOWN, K. C. DOLE, D. E. SCHMECHEL, W. J. STRITTMATTER, M. A. PERICAK-VANCE & A. D. ROSES. 1993, Apolipoprotein E type 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711.
5. ROSES, A. D. 1994. Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease [see comments]. [Review]. J. Neuropathol. Exp. Neurol. 53: 429-437.
6. NALBANTOGLU, J., B. M. GILFIX, P. BERTRAND, Y. ROBITAILLE, S. GAUTHIER, D. S. ROSENBLATT & J. POIRIER. 1994. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann. Neurol. 36: 889-895.
7. VAN GOOL, W. A., H. M. EVENHUIS & C. M. VAN DUIJN ON BEHALF OF THE DUTCH STUDY GROUP ON DOWN'S SYNDROME AND AGEING. 1995. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann. Neurol. 38: 225-230.
8. BASUN, H., M. GRUT, B. WINBLAD & L. LANNFELT. 1995. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci. Lett. 183: 32-34.
9. BERR, C., J. J. HAUW, P. DELAERE, C. DUYCKAERTS & P. AMOUYEL. 1994. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci. Lett. 178: 221-224.
10. HYMAN, B. T., H. L. WEST, G. W. REBECK, S. V. BULDYREV, R. N. MANTEGNA, M. UKLEJA, S. HAVLIN & H. E. STANLEY. 1995. Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. Natl. Acad. Sci. USA 92: 3586-3590.
11. NAMBA, Y., H. TSUCHIYA & K. IKEDA. 1992. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Neurosci. Lett. 134: 264-266.
12. ZUBENKO, G. S., S. STIFFLER, S. STABLER, U. KOPP, H. B. HUGHES, B. M. COHEN & J. MOOSSY. 1994. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am. J. Med. Genet. 54: 199-205.
13. GOEDERT, M., W. J. STRITTMATTER & A. D. ROSES. 1994. Alzheimer's disease. Risky apolipoprotein in brain [news; comment]. Nature 372: 45-46.
14. STRITTMATTER, W. J., K. H. WEISGRABER, M. GOEDERT, A. M. SAUNDERS, D. HUANG, L. M. DONG, R. JAKES, M. J. ALBERTS, J. R. GILBERT, et al. 1994. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. [Review]. Exp. Neurol. 125: 163-71; discussion, 172.
15. POIRIER, J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. [Review]. Trends Neurosci. 17: 525-530.
16. STRITTMATTER, W. J. & A. D. ROSES. 1995. Apolipoprotein E and Alzheimer disease. [Review], Proc. Natl. Acad. Sci. USA 92: 4725-4727.
17. ALZHEIMER, A. 1907. Ueber eine eigenatige Erkrankung der Himrinde. Centralbl. Nervenheilkunde Psychiatrie 30: 146-148.
18. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, R. KATZMAN, D. PRICE & E. M. STADLAN. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
19. ROTH, M., E. TYM, C. Q. MOUNTJOY, F. A. HUPPERT, H. HENDRIE, S. VERMA & R. GODDARD. 1986. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149: 698-709.
20. MIRRA, S. S., A. HEYMAN, D. MCKEEL, S. M. SUMI, B. J. GRAIN, L. M. BROWNLEE, VOGEL, F. S., J. P. HUGHES, G. VAN BELLE & L. BERG. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II, Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
21. MORRIS, J. C., A. HEYMAN, R. C. MOHS, J. P. HUGHES, G. VAN BELLE, G. FILLENBAUM, E. D. MELLITS & C. CLARK. 1989. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39: 1159-1165.
22. WILCOCK, G. K., R. A. HOPE, D. N. BROOKS, P. L. LANTOS, C. OPPENHEIMER, G. P. REYNOLDS, M. N. ROSSOR & M. B. DAVIES. 1989. Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. [Review]. J. Neurol. Neurosurg. Psychiatry 52: 693-700.
23. COLLINGE, J., J. BROWN, J. HARDY, M. MULLAN, M. N. ROSSOR, H. BAKER, T. J. CROW, R. LOFTHOUSE, M. POULTER, R. RIDLEY, et al. 1992. Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115: 687-710.
24. GUSTAFSON, L. 1987. Frontal lobe degeneration of non-Alzheimer type. N. Clinical picture and differential diagnosis. Arch. Gerontol. Geriatr. 6: 209-223.
25. MCKEITH, I. G., A. F. FAIRBAIRN, R. A. BOTHWELL, P. B. MOORE, I. N. FERRIER, P. THOMPSON & R. H. PERRY. 1994. An evaluation of the predictive validity and interrater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 44: 872-877.
26. MASLIAH, E., L. A. HANSEN, S. QUIJADA, R. DETERESA, M. ALFORD, J. KAUSS & R. TERRY. 1991. Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy? [See comments.] Ann. Neurol. 29: 389-396.
27. CRYSTAL, H., D. DICKSON, P. FULD, D. MASUR, R. SCOTT, M. MEHLER, J. MASDEU, C. KAWAS, M. ARONSON & L. WOLFSON. 1988. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 38: 1682-1687.
28. CRYSTAL, H. A., D. S. HOROUPIAN, R. KATZMAN & S. JOTKOWITZ. 1982. Biopsy-proved Alzheimer disease presenting as a right parietal lobe syndrome. Ann. Neurol. 12: 186-188.
29. JAGUST, W. J., P. DAVIES, J. K. TILLER-BORICICH & B. R. REED. 1990. Focal Alzheimer's disease. Neurology 40: 14-19.
30. WILL, R. G. & W. B. MATTHEWS. 1984. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J. Neurol. Neurosurg. Psychiatry 47: 134-140.
31. BOERMAN, R. H., P. SCHELTENS & H. C. WEINSTEIN. 1994. Clinical neurophysiology in the diagnosis of Alzheimer's disease. [Review], Clin. Neurol. Neurosurg. 96: 111-118.
32. SCHELTENS, P., H. C. WEINSTEIN & D. LEYS. 1992. Neuro-imaging in the diagnosis of Alzheimer's disease. I. Computer tomography and magnetic resonance imaging. [Review]. Clin. Neurol. Neurosurg. 94: 277-289.
33. WEINSTEIN, H. C., P. SCHELTENS, A. HIJDRA & E. A. VAN ROYEN. 1993. Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography. [Review]. Clin. Neurol. Neurosurg. 95: 81-91.
34. VAN GOOL, W. A. & P. A. BOLHUIS. 1991. Cerebrospinal fluid markers of Alzheimer's disease. [Review]. J. Am. Geriatr. Soc. 39: 1025-1039.
35. WILSON, P. W. 1995. Relation of high-density lipoprotein subfractions and apolipoprotein E isoform to coronary disease. [Review]. Clin. Chem. 41: 165-169.
36. MURPHY, J. R. 1983. The relationship of relative risk and positive predictive value in 2 × 2 tables. Am. J. Epidemiol. 117: 86-89.
37. ROSE, G. 1981. Strategy of prevention: Lessons from cardiovascular disease. Br. Med. J. Clin. Res. Ed. 282: 1847-1851.
38. MALENKA, D. J. & J. A. BARON. 1988. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk. Arch. Int. Med. 148: 2247-2252.
39. BARON, J. A. 1989. The clinical utility of risk factor data. J. Clin. Epidemiol. 42: 1013-1020.
40. CZECH, C., V. MONNING, P. J. TIENARI, T. HARTMANN, C. MASTERS & K. BEYREUTHER. 1993. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease [letter]. Lancet 342: 1309.
41. REBECK, G. W., T. T. PERLS, H. L. WEST, P. SODHI, L. A. LIPSITZ & B. T. HYMAN. 1994. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 44: 1513-1516.
42. BROUSSEAU, T., S. LEGRAIN, C. BERR, V. GOURLET, O. VIDAL & P. AMOUYEL. 1994. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 44: 342-344.
43. KAWAMATA, J., S. TANAKA, S. SHIMOHAMA, K. UEDA & J. KIMURA. 1994. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J. Neurol. Neurosurg. Psychiatry 57: 1414-1416.
44. UEKI, A., M. KAWANO, Y. NAMBA, M. KAWAKAMI & K. IKEDA. 1993. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease Neurosci. Lett. 163: 166-168.
45. MAYEUX, R., Y. STERN, R. OTTMAN, T. K. TATEMICHI, M. X. TANG, G. MAESTRE, NGAI C., B. TYCKO & H. GINSBERG. 1993. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease [see comments]. Ann. Neurol. 34: 752-754.
46. KUUSISTO, J., K. KOIVISTO, K. KERVINEN, L. MYKKANEN, E. L. HELKALA, VANHANEN M., T. HANNINEN, K. PYORALA, Y. A. KESANIEMI, P. RIEKKINEN et al. 1994. Association of apolipoprotein E phenotype with late onset Alzheimer's disease: Population based study. Br. Med. J. 309: 636-638.
47. SMITH, A. D., C. JOHNSTON, E. SIM, Z. NAGY, K. A. JOBST, N. HINDLEY & E. KING. 1994. Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA) [letter; comment]. Lancet 344: 473-474.
48. FRISONI, G. B., S. GOVONI, C. GEROLDI, A. BIANCHETTI, L. CALABRESI, G. FRANCESCHINI & M. TRABUCCHI. 1995. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 37: 596-604.
49. SORBI, S., B. NACMIAS, P. FORLEO, S. LATORRACA, I. GOBBINI, L. BRACCO, S. PIACENTINI & L. AMADUCCI. 1994. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett. 177: 100-102.
50. TSAI, M. S., E. G. TANGALOS, R. C. PETERSEN, G. E. SMITH, D. J. SCHAID, E. KOKMEN & S. N. THIBODEAU. 1994. Apolipoprotein E: Risk factor for Alzheimer disease. Am. J. Hum. Genet. 54: 643-649.
51. SAKODA, S., M. KURIYAMA, M. OSAME, K. TAKAHASHI, T. YAMANO, J. SASAKI & A. MATSUNAGA. 1994. Apolipoprotein E epsilon 4 [letter; comment]. Neurology 44: 2420; discussion 242.
52. LIDDELL, M., J. WILLIAMS. A. BAYER, F. KAISER & M. OWEN. 1994. Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. J. Med. Genet. 31: 197-200.
53. POIRIER, J., J. DAVIGNON, D. BOUTHILLIER, S. KOGAN, P. BERTRAND & S. GAUTHIER. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
54. CORDER, E. H., A. M. SAUNDERS, N. J. RISCH, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, J. B. RIMMLER, P. A. LOCKE, P. M. CONNEALLY, K. E. SCHMADER, G. W. SMALL, A. D. ROSES, J. L. HAINES & M. A. PERICAK-VANCE. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7: 180-184.
55. LIPPA, C. F., T. W. SMITH, A. M. SAUNDERS, R. CROOK, D. PULASKI-SALO, P. DAVIES, J. HARDY, A. D. ROSE & D. DICKSON. 1995. Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97-103.
56. ZERR, I., M. HELMHOLD, V. W. ARMSTRONG & T. WEBER. 1995. Apolipoprotein E in Creutzfeldt-Jakob disease [letter; comment] [published erratum appears in Lancet 1995 Jan 28; 345(8944):266]. Lancet 345: 68-69.
57. COUDERC, R., F. MAHIEUX, S. BAILLEUL, G. FENELON, R. MARY & J. FERMANIAN. 1993. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study [see comments]. Stroke 24: 661-664.
58. SCHNEIDER, J. A., M. GEARING, R. S. ROBBINS, I. DE, W & S. S. MIRRA. 1995. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann. Neurol. 38: 131-135.
59. NAKAGAWA, Y., T. KITAMOTO, H. FURUKAWA, K. OGOMORI & J. TATEISHI. 1995. Apolipoprotein E in Creutzfeldt-Jakob disease [letter; comment]. Lancet 345: 68.
60. PODUSLO, S. E., D. RIGGS, T. ROLAN & J. SCHWANKHAUS. 1995. Apolipoprotein E and B alleles in Parkinson's patients. Neurosci. Lett. 194: 145-147.
61. AMOUYEL, P., O. VIDAL, J. M. LAUNAY & J. L. LAPLANCHE. 1994. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies [see comments]. Lancet 344: 1315-1318.
62. MARDER, K., G. MAESTRE, L. COTE, H. MEJIA, B. ALFARO, A. HALIM, M. TANG & R. MAYEUX. 1994. The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia. Neurology 44: 1330-1331.
63. KOLLER, W. C., S. L. GLATT, J. P. HUBBLE, A. PAOLO, A. I. TROSTER, M. S. HANDLER, R. T. HORVAT, C. MARTIN, K. SCHMIDT, A. KARST, et al. 1995. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann. Neurol. 37: 242-245.
64. HARRINGTON, C. R., J. LOUWAGIE, R. ROSSAU, E. VANMECHELEN, R. H. PERRY, E. K. PERRY, J. H. XUEREB, M. ROTH & C. M. WISCHIK. 1994. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am. J. Pathol. 145: 1472-1484.
65. KAMBOH, M. I. 1995. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. [Review]. Hum. Biol. 67: 195-215.
66. OSUNTOKUN, B. O., A. SAHOTA, A. O. OGUNNIYI, O. GUREJE, O. BAIYEWU, A. ADEYINKA, S. O. OLUWOLE, O. KOMOLAFE, K. S. HALL, F. W. UNVERZAGT, S. L. HUI, M. YANG & H. C. HENDRIE. 1995. Lack of association between apolipoprotein epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 38: 463-465.
67. REBECK, G. W., T. T. PERLS, H. L. WEST, P. SODHI, L. A. LIPSITZ & B. T. HYMAN. 1994. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals [published erratum appears in Neurology 1995 Mar;45(3 Pt 1):598]. Neurology 44: 1513-1516.
68. SOX, H. C., A. B. MARSHAL & M. C. HIGGINS, EDS. 1988. Medical Decision Making. Butterworths.
69. PAUKER, S. G. & J. P. KASSIRER. 1975. Therapeutic decision making: A cost-benefit analysis. N. Engl. J. Med. 293: 229-234.
70. COREY-BLOOM, J., L. J. THAL, D. GALASKO, M. FOLSTEIN, D. DRACHMAN, M. RASKIND & D. J. LANSKA. 1995. Diagnosis and evaluation of dementia. [Review]. Neurology 45: 211-218.
71. GEARING, M., S. S. MIRRA, J. C. HEDREEN, S. M. SUMI, L. A. HANSEN & A. HEYMAN. 1995. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45: 461-466.
72. MENDEZ, M. F., A. R. MASTRI, J. H. SUNG & W. H. FREY, 2d. 1992. Clinically diagnosed Alzheimer disease: Neuropathologic findings in 650 cases. Alzheimer Dis. Assoc. Disord. 6: 35-43.
73. VAN GOOL, W. A., G. J. M. WALSTRA, S. TEUNISSE, F. M. VANDER ZANT, H. C. WEINSTEIN & E. A. VAN ROYEN. 1995. Diagnosing Alzheimer's disease in elderly, mildly demented patients: The impact of routine single photon emission computed tomography. J. Neurol. 242: 401-405.